Simcere Pharmaceutical Group Limited at its Extraordinary General Meeting Held on January 18, 2023, announce that, the appointment of Ms. WANG Xi as an executive Director and the appointment of Mr. SUNG Ka Woon as an independent non-executive Director have been approved by the Shareholders at the EGM by way of ordinary resolutions.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.14 HKD | -0.96% | -1.72% | -23.63% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.63% | 1.71B | |
+19.84% | 43.54B | |
+16.96% | 21.74B | |
+8.52% | 13.02B | |
+6.06% | 13.53B | |
+33.98% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.71% | 5.09B |
- Stock Market
- Equities
- 2096 Stock
- News Simcere Pharmaceutical Group Limited
- Simcere Pharmaceutical Group Limited Announces Appointment Wang Xi as an Executive Director and the Appointment of Sung Ka Woon as an Independent Non-Executive Director